Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Study of Individuals and Families at High Risk for Cancer
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Individuals and Families at High Risk for Cancer
Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic and Clinical Study of Patients With Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic and Clinical Study of Patients With Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Psychological Benefits of Camping in Treating Children With Cancer
Psychological Benefits of a "Normalized" Camping Experience for Children With Cancer
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Psychological Benefits of Camping in Treating Children With Cancer
Psychological Benefits of a "Normalized" Camping Experience for Children With Cancer
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Biological Therapy and Combination Chemotherapy in Treating Patients With Lymphomatoid Granulomatosis
Treatment & Natural History of Lymphomatoid Granulomatosis
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Biological Therapy and Combination Chemotherapy in Treating Patients With Lymphomatoid Granulomatosis
Treatment & Natural History of Lymphomatoid Granulomatosis
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic Study of Patients With Inherited Urologic Malignancies
Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic Study of Patients With Inherited Urologic Malignancies
Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Patient Eligibility for Participation in Surgery Clinical Trials
Evaluation for NCI Surgery Branch Clinical Research Protocols
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Patient Eligibility for Participation in Surgery Clinical Trials
Evaluation for NCI Surgery Branch Clinical Research Protocols
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Screening Study of Patient Eligibility for Participation in National Cancer Institute Radiation Therapy Clinical Trials
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Screening Study of Patient Eligibility for Participation in National Cancer Institute Radiation Therapy Clinical Trials
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
Pilot Study Of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation For Pediatric Hematopoietic Malignancies
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Chemotherapy Followed by Allogeneic Stem Cell Transplantation in Treating Children With Hematologic Cancer
Pilot Study Of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation For Pediatric Hematopoietic Malignancies
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
BMS 247550 to Treat Kidney Cancer
A Phase II Clinical Trial of BMS-247550 (NSC 710428), an Epothilone B Analog, in Renal Cell Carcinoma
Status: Archived
National Institutes of Health Clinical Center
2277
mi
from 91732
Bethesda, MD
BMS 247550 to Treat Kidney Cancer
A Phase II Clinical Trial of BMS-247550 (NSC 710428), an Epothilone B Analog, in Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
2277
mi
from 91732
Bethesda, MD
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Status: Archived
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Genetic Study of Patients and Families With Birt-Hogg-Dube Syndrome
The Birt Hogg Dube Syndrome: Identification Of The Disease Gene And Characterization Of The Predisposition To Renal Cancer
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic Study of Patients and Families With Birt-Hogg-Dube Syndrome
The Birt Hogg Dube Syndrome: Identification Of The Disease Gene And Characterization Of The Predisposition To Renal Cancer
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Individuals and Families at High Risk for Testicular Cancer
Multidisciplinary Etiologic Study Of Familial Testicular Cancer
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Individuals and Families at High Risk for Testicular Cancer
Multidisciplinary Etiologic Study Of Familial Testicular Cancer
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Screening Trial to Study Eligibility of Patients to Participate in Head and Neck Surgery Clinical Trials
Evaluation For NIDCD Head And Neck Surgery Branch Clinical Research Protocols
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Screening Trial to Study Eligibility of Patients to Participate in Head and Neck Surgery Clinical Trials
Evaluation For NIDCD Head And Neck Surgery Branch Clinical Research Protocols
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
Study of Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization Of Individuals And Families At High Risk Of Breast/Ovarian Cancer
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
Study of Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization Of Individuals And Families At High Risk Of Breast/Ovarian Cancer
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Cancer Risk in Individuals Who Have a Xeroderma Pigmentosum Gene Alteration Compared With Those Who Don't
Cancer Risk In Xeroderma Pigmentosum Heterozygotes
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Cancer Risk in Individuals Who Have a Xeroderma Pigmentosum Gene Alteration Compared With Those Who Don't
Cancer Risk In Xeroderma Pigmentosum Heterozygotes
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Screening Individuals and Families at High Risk for Hematologic Cancers
Clinical, Laboratory And Epidemiologic Characterization Of Individuals And Families At High Risk Of Hematologic Cancer
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Screening Individuals and Families at High Risk for Hematologic Cancers
Clinical, Laboratory And Epidemiologic Characterization Of Individuals And Families At High Risk Of Hematologic Cancer
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
1730
mi
from 91732
Chicago, IL
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
Updated: 1/1/1970
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
1730
mi
from 91732
Chicago, IL
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
Fox Chase Cancer Center
2379
mi
from 91732
Philadephia, PA
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
Updated: 1/1/1970
Fox Chase Cancer Center
2379
mi
from 91732
Philadephia, PA
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
Cancer Therapy and Research Center
1182
mi
from 91732
San Antonio, TX
Study of Decision Making in Patients Participating in Phase I Clinical Trials
Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
Status: Archived
Updated: 1/1/1970
Cancer Therapy and Research Center
1182
mi
from 91732
San Antonio, TX
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
Pilot Study Of Multiple Umbilical Cord Blood Unit Transplantation Following Non-Myeloablative Conditioning In Patients With Hematologic Disorders Or Severe Aplastic Anemia
Status: Archived
Case Western Reserve Univ
2036
mi
from 91732
Cleveland, OH
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
Pilot Study Of Multiple Umbilical Cord Blood Unit Transplantation Following Non-Myeloablative Conditioning In Patients With Hematologic Disorders Or Severe Aplastic Anemia
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
2036
mi
from 91732
Cleveland, OH
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
University of Chicago
1730
mi
from 91732
Chicago, IL
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Updated: 1/1/1970
University of Chicago
1730
mi
from 91732
Chicago, IL
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Holden Comprehensive Cancer Center at University of Iowa
1528
mi
from 91732
Iowa City, IA
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Updated: 1/1/1970
Holden Comprehensive Cancer Center at University of Iowa
1528
mi
from 91732
Iowa City, IA
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Cooper Health System
2408
mi
from 91732
Franklin Twp, NJ
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Updated: 1/1/1970
Cooper Health System
2408
mi
from 91732
Franklin Twp, NJ
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Metro Health Medical Center
2031
mi
from 91732
Cleveland, OH
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Updated: 1/1/1970
Metro Health Medical Center
2031
mi
from 91732
Cleveland, OH
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
1959
mi
from 91732
Columbus, OH
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Updated: 1/1/1970
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
1959
mi
from 91732
Columbus, OH
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Ohio Health Research Institute / Riverside Methodist Hospital
1959
mi
from 91732
Columbus, OH
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Updated: 1/1/1970
Ohio Health Research Institute / Riverside Methodist Hospital
1959
mi
from 91732
Columbus, OH
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Oklahoma University Cancer Institute
1166
mi
from 91732
Oklahoma City, OK
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase I Study Of Pelvic Radiation Therapy With Concomitant Cisplatin And Weekly Topotecan (IND# 58,13) Chemotherapy In Patients With Cervical Carcinoma And Paraortic Nodal Metastasis As The Only Evidence Of Extrapelvic Disease
Status: Archived
Updated: 1/1/1970
Oklahoma University Cancer Institute
1166
mi
from 91732
Oklahoma City, OK
Genetic Study of Cancer Risk and Gene Identification in Patients and Families With Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification Of The Disease Gene And Characterization of The Predisposition To Renal Cancer
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic Study of Cancer Risk and Gene Identification in Patients and Families With Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification Of The Disease Gene And Characterization of The Predisposition To Renal Cancer
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Jonsson Comprehensive Cancer Center at UCLA
24
mi
from 91732
Los Angeles, CA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Updated: 1/1/1970
Jonsson Comprehensive Cancer Center at UCLA
24
mi
from 91732
Los Angeles, CA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Stanford University Dept. of Medicine-Oncology
328
mi
from 91732
Stanford, CA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Updated: 1/1/1970
Stanford University Dept. of Medicine-Oncology
328
mi
from 91732
Stanford, CA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
UCSF Helen Diller Family Comprehensive Cancer Center
356
mi
from 91732
San Francisco, CA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Updated: 1/1/1970
UCSF Helen Diller Family Comprehensive Cancer Center
356
mi
from 91732
San Francisco, CA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
2277
mi
from 91732
Bethesda, MD
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Fred Hutchinson Cancer Research Center
962
mi
from 91732
Seattle, WA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Updated: 1/1/1970
Fred Hutchinson Cancer Research Center
962
mi
from 91732
Seattle, WA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
University of Washington
943
mi
from 91732
Seattle, WA
Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
Etiologic Investigation Of Cancer Susceptibility In Inherited Bone Marrow Failure Syndromes: A Natural History Study
Status: Archived
Updated: 1/1/1970
University of Washington
943
mi
from 91732
Seattle, WA
Safety Study of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Treat Relapsed EBV-Positive Lymphoma,
The Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma.
Status: Archived
Texas Children's Hospital - Feigin Center
1357
mi
from 91732
Houston, TX
Safety Study of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Treat Relapsed EBV-Positive Lymphoma,
The Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma.
Status: Archived
Updated: 1/1/1970
Texas Children's Hospital - Feigin Center
1357
mi
from 91732
Houston, TX
Safety Study of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Treat Relapsed EBV-Positive Lymphoma,
The Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma.
Status: Archived
Houston Methodist Hospital
1357
mi
from 91732
Houston, TX
Safety Study of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Treat Relapsed EBV-Positive Lymphoma,
The Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma.
Status: Archived
Updated: 1/1/1970
Houston Methodist Hospital
1357
mi
from 91732
Houston, TX
Safety Study of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Treat Relapsed EBV-Positive Lymphoma,
The Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma.
Status: Archived
Baylor School of Medicine
1357
mi
from 91732
Houston, TX
Safety Study of Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Treat Relapsed EBV-Positive Lymphoma,
The Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma.
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
1357
mi
from 91732
Houston, TX
Intraperitoneal Floxuridine in Gastric Carcinoma
Intraperitoneal Floxuridine in Gastric Carcinoma
Status: Archived
Los Angeles County-USC Medical Center
11
mi
from 91732
Los Angeles, CA
Intraperitoneal Floxuridine in Gastric Carcinoma
Intraperitoneal Floxuridine in Gastric Carcinoma
Status: Archived
Updated: 1/1/1970
Los Angeles County-USC Medical Center
11
mi
from 91732
Los Angeles, CA
Intraperitoneal Floxuridine in Gastric Carcinoma
Intraperitoneal Floxuridine in Gastric Carcinoma
Status: Archived
New York University Langone Medical Center
2434
mi
from 91732
New York, NY
Intraperitoneal Floxuridine in Gastric Carcinoma
Intraperitoneal Floxuridine in Gastric Carcinoma
Status: Archived
Updated: 1/1/1970
New York University Langone Medical Center
2434
mi
from 91732
New York, NY
Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer
Phase I Study Of Intravenous DOTAP:Cholesterol-Fus1 Liposome Complex (DOTAP:Chol-fus1) In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy
Status: Archived
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
1182
mi
from 91732
San Antonio, TX
Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer
Phase I Study Of Intravenous DOTAP:Cholesterol-Fus1 Liposome Complex (DOTAP:Chol-fus1) In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy
Status: Archived
Updated: 1/1/1970
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
1182
mi
from 91732
San Antonio, TX
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Alaska Regional Hospital Cancer Center
2341
mi
from 91732
Anchorage, AK
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Alaska Regional Hospital Cancer Center
2341
mi
from 91732
Anchorage, AK
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
1342
mi
from 91732
Ft. Smith, AR
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
1342
mi
from 91732
Ft. Smith, AR
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
1460
mi
from 91732
Little Rock, AR
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
1460
mi
from 91732
Little Rock, AR
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Providence Saint-Joseph Medical Center
19
mi
from 91732
Burbank, CA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Providence Saint-Joseph Medical Center
19
mi
from 91732
Burbank, CA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Breastlink Med Group Inc
21
mi
from 91732
Long Beach, CA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Breastlink Med Group Inc
21
mi
from 91732
Long Beach, CA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
CCOP - Atlanta Regional
1918
mi
from 91732
Atlanta, GA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
CCOP - Atlanta Regional
1918
mi
from 91732
Atlanta, GA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Saint Joseph's Hospital of Atlanta
1918
mi
from 91732
Atlanta, GA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Saint Joseph's Hospital of Atlanta
1918
mi
from 91732
Atlanta, GA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Northside Hospital
1918
mi
from 91732
Atlanta, GA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Northside Hospital
1918
mi
from 91732
Atlanta, GA